“When we came to the point where we had to stand up an enterprise-grade streaming data platform, we looked at multiple options and Confluent was a clear winner here.”
"We have been very satisfied with Confluent Platform as the backbone of our persistence engine. The platform has been super reliable. We have stringent requirements for real-time performance and reliability, and we have confirmed – from proof-of-concept to deployment of a cutting-edge production trading platform – that we made the right decision."
“Banks can’t expect to go on operating on outdated technology. Traditional banks can’t expect to move into the future without using data in real time. Confluent helps us set our data in motion.”
“With Confluent’s fully managed data streaming platform, we are able to focus on the business side of things, like governance and the metrics around data. As we are evaluating Confluent’s fully managed data streaming platform, we recognize that it will enable us to focus on the business side of things, like governance and the metrics around data. It will allow us to manage complex cluster failure scenarios by seamlessly migrating traffic to an asynchronous DR cluster.”
"With Confluent Cloud we have none of the overhead or worries that come with self-managing. We have a guaranteed 99.95% uptime SLA, access to 24x7 expert Kafka support, and access to the latest Kafka developments."
“We started wondering, can we offload all of the management of Kafka—and still get all of the benefits of Kafka? That’s when Confluent came into the picture.”
"To provide accurate and current data across the Trimble Platform, it requires streaming data pipelines that connect our internal services and data systems across the globe. Custom connectors will allow us to quickly bridge our in-house event service and Kafka without setting up and managing the underlying connector infrastructure. We will be able to easily upload our custom-built connectors to seamlessly stream data into Confluent and shift our focus to higher-value activities."
"Confluent and Google Cloud enabled us to address our large database footprint and retire our legacy data platform, which was in many ways our Achilles heel. After moving to real-time streaming on a cloud-based modern architecture, we can now deliver new features and capabilities to our customers and know that they won’t be slowed by an outdated architecture."
"We know that Confluent Platform and Apache Kafka will continue to help us scale."
"Confluent sits at the very core of our entire platform and modern payments business, serving as the underlying data mesh for everything we do today and anything we may want to do in the future. Operating around real-time, trusted data streams fueled by the entire business means every team is equipped with the data they need to build rich, personalized experiences for our customers while maintaining the flexibility to easily change or evolve solutions as our business grows."
"Working with the Apache Kafka experts at Confluent gives us the confidence to scale the data pipeline, improving business operations and overall reliability."
"With Kafka, we can liberate data from our heritage systems and combine it with real-time signals from our customers to deliver a hyper-personalized experience. For example, if our clickstream data shows a customer lingering over a product they looked at in the past, we can push a voucher to them in real time to create more compelling propositions for customers. You just can’t do that with a data lake and batch processing."
“At Victoria’s Secret, data is key for empowering agile decision making. We receive data from various systems including logistics, stores, and digital systems.”
"With the ability to combine real-time results with historical events, Confluent is leading the charge in helping enterprises discover new services and modernize existing ones with the power of event streaming."
"The scale and robustness of the system we built with Confluent Cloud have played a key role in accelerating our success in our mission of discovering new treatments and has helped us bring new treatments to human clinical trials."